CAS: 356057-34-6 - Darapladib

Formel: C₃₆H₃₈F₄N₄O₂S

InChl: InChI=1S/C36H38F4N4O2S/c1-3-42(4-2)20-21-43(22-25-8-12-27(13-9-25)28-14-16-29(17-15-28)36(38,39)40)33(45)23-44-32-7-5-6-31(32)34(46)41-35(44)47-24-26-10-18-30(37)19-11-26/h8-19H,3-7,20-24H2,1-2H3

InChI Key: InChIKey=WDPFJWLDPVQCAJ-UHFFFAOYSA-N

SMILES: O=C1N=C(SCC2=CC=C(F)C=C2)N(C3=C1CCC3)CC(=O)N(CC4=CC=C(C=C4)C=5C=CC(=CC5)C(F)(F)F)CCN(CC)CC

Synonyme:

• 1-[[[N-[2-(Diethylamino)ethyl]-N-[4-[4-(trifluoromethyl)phenyl]benzyl]amino]carbonyl]methyl]-2-(4-fluorobenzylthio)-5,6-trimethylenepyrimidin-4-one
• 1H-Cyclopentapyrimidine-1-acetamide, N-[2-(diethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-N-[[4′-(trifluoromethyl)[1,1′-biphenyl]-4-yl]methyl]-
• 480848
• Darapladib
• Darapladib (SB-480848)
• N-[2-(Diethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-N-[[4′-(trifluoromethyl)[1,1′-biphenyl]-4-yl]methyl]-1H-cyclopentapyrimidine-1-acetamide
• N-[2-(diethylamino)ethyl]-2-{2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}-N-{[4'-(trifluoromethyl)biphenyl-4-yl]methyl}acetamide
• Sb 435445
• Sb-480848

Darapladib

CAS: 356057-34-6

• Formel: C₃₆H₃₈F₄N₄O₂S
• Reinheit: 98%
• Farbe und Form: Solid
• Molekulargewicht: 666.7711

Darapladib

CAS: 356057-34-6

Darapladib (SB-480848) is a lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor with an IC50 value of 0.25 …

• Formel: C₃₆H₃₈F₄N₄O₂S
• Reinheit: 100% - 99.85%
• Farbe und Form: Solid
• Molekulargewicht: 666.77

DARAPLADIB

CAS: 356057-34-6

• Reinheit: 95%
• Molekulargewicht: 666.780029296875

Darapladib

CAS: 356057-34-6

Inhibitor of lipoprotein-associated phospholipase A2

• Formel: C₃₆H₃₈F₄N₄O₂S
• Reinheit: Min. 98 Area-%
• Farbe und Form: Powder
• Molekulargewicht: 666.77 g/mol

Darapladib - Bio-X ™

CAS: 356057-34-6

This product is part of our Bio-X ™ Range. These products are aimed at life …

• Formel: C₃₆H₃₈F₄N₄O₂S
• Reinheit: Min. 95%
• Farbe und Form: Powder
• Molekulargewicht: 666.77 g/mol